PMID: 6986945Jan 5, 1980Paper

Venous lipodermatosclerosis: treatment by fibrinolytic enhancement and elastic compression

British Medical Journal
K BurnandN L Browse

Abstract

The value of fibrinolytic enhancement with an anabolic steroid (stanozolol) combined with elastic stockings in treating venous lipodermatosclerosis was assessed in a six-month double-blind cross-over trial. Thirty-four legs of 23 patients in whom other treatments had failed were studied. The patients were randomly divided into two groups who were treated with either stanozolol plus elastic stockings or placebo plus elastic stockings for three months, and then vice versa. Treatment with or without stanozolol caused the area of lipodermatosclerosis to decrease, but the rate of healing when patients took stanozolol was double that when they took the placebo, and this was assumed to be biologically important. Stanozolol also reduced the incidence of extravascular fibrin detected in skin biopsy specimens. The elastic stocking with placebo produced significant decreases in leg volume, ankle circumference, and skin thickness. Stanozolol is valuable in treating intractable lipodermatosclerosis, giving relief of pain and reducing induration, inflammation, tenderness, and pigmentation.

References

Feb 19, 1977·British Medical Journal·N L BrowseM Morland
Sep 1, 1969·The British Journal of Dermatology·M M Black

❮ Previous
Next ❯

Citations

Dec 1, 1986·World Journal of Surgery·N L Browse
Dec 17, 2009·Internal and Emergency Medicine·Raffaele PesaventoPaolo Prandoni
Jul 31, 1982·Lancet·N L Browse, K G Burnand
Jul 31, 1982·Lancet
Aug 27, 1983·Lancet·F E PrestonD S Segal
Aug 1, 1997·Cardiovascular Surgery : Official Journal of the International Society for Cardiovascular Surgery·J J RicottaT G Lynch
Apr 1, 1993·International Journal of Dermatology·G MulderT Ryan
Oct 1, 1995·International Journal of Dermatology·T Lotti, M Benci
Apr 1, 1991·The Australian and New Zealand Journal of Surgery·G M McMullinJ H Scurr
Jul 1, 1992·The Journal of Dermatologic Surgery and Oncology
Aug 1, 1993·The Journal of Dermatologic Surgery and Oncology·V Falanga
Jun 18, 1983·British Medical Journal·N L Browse
Sep 8, 1984·British Medical Journal·A D Ormerod, M I White
Jul 26, 1986·British Medical Journal·K G Burnand, G T Layer
Mar 7, 1987·British Medical Journal·R S EvelyR Williams
Feb 6, 1988·British Medical Journal·A J Whitley
Nov 4, 2000·Postgraduate Medical Journal·P K Sarkar, S Ballantyne
Nov 14, 1997·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·M Van de Scheur, V Falanga
Jan 1, 1995·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·M P GoldmanR A Weiss
Sep 1, 1986·Journal of Pharmacological Methods·C G KirsteinH Berger
Apr 27, 2012·Journal des maladies vasculaires·B VillemurM-P De Angelis
May 15, 2010·Journal of the American Academy of Dermatology·Sarah N Walsh, Daniel J Santa Cruz
Apr 1, 1993·Journal of the American Academy of Dermatology·R S KirsnerV Falanga
Jul 1, 1994·Journal of the American Academy of Dermatology·K Ongenae, T Phillips
Sep 8, 2007·Annals of Vascular Surgery·Gregory S BarronRobert S Kirsner
Feb 1, 1989·Journal of the American Academy of Dermatology·A J NemethV Falanga
Feb 19, 2009·British Journal of Haematology·Paolo Prandoni, Susan R Kahn
Mar 13, 2009·Journal of Cutaneous Pathology·Tsung-Mao Huang, Julia Y-Y Lee
Jul 30, 2010·Dermatologic Therapy·Maria MitevaRobert S Kirsner
Aug 1, 1995·Journal of the American Academy of Dermatology·T Helfman, V Falanga
May 1, 1993·American Journal of Surgery·W T Wong
Jun 20, 2006·Journal of the American Academy of Dermatology·Lisa B Campbell, O Fred Miller
Mar 5, 1998·Journal of the American Academy of Dermatology·D Parsad, R Saini
Dec 8, 1998·Journal of the American Academy of Dermatology·M GniadeckaA Bertram
Jun 1, 1997·The Surgical Clinics of North America·W H Eaglstein, V Falanga
Oct 15, 1986·Thrombosis Research·M SmallC D Forbes
Jan 1, 1992·Scandinavian Journal of Rheumatology·J E NaschitzJ H Boss

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.